Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
{{output}}
It is important that patient-reported outcome (PRO) measures used to assess cancer therapies adequately capture the benefits and risks experienced by patients, particularly when adverse event profiles differ across therapies. This study explores the case for a... ...
